[ad_1] Flexion Therapeutics (FLXN): The company maintained a gross margin of 60.50%. The Insiders property is 0.50%. The company has maintained the return on investment (ROI) to -30.90% in the previous 12 months and was able to maintain the return on invested capital (ROA) to -46.90% in the last twelve …
Read More »